Ali Cansu

1.9k total citations
98 papers, 1.2k citations indexed

About

Ali Cansu is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Ali Cansu has authored 98 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pediatrics, Perinatology and Child Health, 36 papers in Psychiatry and Mental health and 18 papers in Molecular Biology. Recurrent topics in Ali Cansu's work include Epilepsy research and treatment (29 papers), Pharmacological Effects and Toxicity Studies (26 papers) and Genetics and Neurodevelopmental Disorders (10 papers). Ali Cansu is often cited by papers focused on Epilepsy research and treatment (29 papers), Pharmacological Effects and Toxicity Studies (26 papers) and Genetics and Neurodevelopmental Disorders (10 papers). Ali Cansu collaborates with scholars based in Türkiye, United States and Canada. Ali Cansu's co-authors include Ayşe Serdaroğlu, Tuğba Hırfanoğlu, Síbel A. Özkan, Sabahat Tezcan, Kıvılcım Gücüyener, Sevim Şahin, Orhun Çamurdan, Peyamı Cınaz, Deniz Erdoğan and Seren Gülşen Gürgen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Nutrition and PLoS Genetics.

In The Last Decade

Ali Cansu

82 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Cansu Türkiye 21 605 572 189 128 109 98 1.2k
Savita Sapra India 17 573 0.9× 396 0.7× 81 0.4× 110 0.9× 123 1.1× 50 989
Semra Hız Kurul Türkiye 19 440 0.7× 405 0.7× 295 1.6× 77 0.6× 157 1.4× 104 1.2k
Anne Tournay United States 13 560 0.9× 333 0.6× 141 0.7× 111 0.9× 131 1.2× 20 1.1k
I‐Ching Chou Taiwan 21 461 0.8× 297 0.5× 293 1.6× 227 1.8× 179 1.6× 101 1.4k
Shaul Harel Israel 25 398 0.7× 1.5k 2.6× 236 1.2× 112 0.9× 124 1.1× 80 2.2k
Divya S. Khurana United States 22 757 1.3× 581 1.0× 182 1.0× 46 0.4× 222 2.0× 69 1.4k
Ignacio Valencia United States 27 988 1.6× 685 1.2× 199 1.1× 52 0.4× 279 2.6× 84 1.8k
Pedro J. Serrano‐Castro Spain 22 618 1.0× 360 0.6× 183 1.0× 134 1.0× 248 2.3× 132 1.7k
Akio Nakai Japan 19 241 0.4× 243 0.4× 147 0.8× 98 0.8× 89 0.8× 74 1.1k
Burak Tatlı Türkiye 18 208 0.3× 362 0.6× 198 1.0× 35 0.3× 69 0.6× 80 994

Countries citing papers authored by Ali Cansu

Since Specialization
Citations

This map shows the geographic impact of Ali Cansu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Cansu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Cansu more than expected).

Fields of papers citing papers by Ali Cansu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Cansu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Cansu. The network helps show where Ali Cansu may publish in the future.

Co-authorship network of co-authors of Ali Cansu

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Cansu. A scholar is included among the top collaborators of Ali Cansu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Cansu. Ali Cansu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kılıç, Betül, Pınar Gençpınar, Nihal Olgaç Dündar, et al.. (2024). Evaluation of seizure semiology, genetics, magnetic resonance imaging, and electroencephalogram findings in children with Rett syndrome: A multicenter retrospective study. Epilepsy Research. 205. 107399–107399. 1 indexed citations
3.
Cansu, Ali, et al.. (2023). A novel INPP4A mutation with pontocerebellar hypoplasia, myoclonic epilepsy, microcephaly, and severe developmental delay. Brain and Development. 45(5). 300–305. 2 indexed citations
5.
Yaman, Hüseyin, Pınar Özkan, Elif Acar Arslan, et al.. (2022). Evaluation of Long-Term Effects of Levetiracetam Monotherapy on Hematological and Liver Function Parameters in Children With Idiopathic Epilepsy. Turkish Journal of Pediatric Disease. 16(2). 144–149.
6.
Gürgen, Seren Gülşen, et al.. (2022). An investigation of the effects of chronic zonisamide, sultiam, lacosamide, clobazam, and rufinamide anti‐seizure medications on foliculogenesis in ovarian tissue in prepubertal non‐epileptic rats. International Journal of Developmental Neuroscience. 82(5). 436–446. 1 indexed citations
7.
Kılıç, Betül, Yasemin Topçu, Ayşe Serdaroğlu, et al.. (2022). Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020. Seizure. 99. 48–53. 3 indexed citations
8.
Arslan, Elif Acar, et al.. (2020). The Importance of Hyponatremia İn Febrile Seizure. Güncel Pediatri. 18(1). 53–62.
9.
Arslan, Elif Acar, et al.. (2020). Febril nöbette hiponatreminin önemi. Güncel Pediatri. 18(1). 53–62.
10.
Arslan, Elif Acar, et al.. (2018). A rare cause of chronic ataxia in childhood: ganglioneuroma. World Journal of Pediatrics. 14(2). 204–206.
11.
Tatlı, Özgür, Yunus Karaca, Süha Türkmen, et al.. (2017). The effect of mad honey on testosterone levels of male rats. Bratislavské lekárske listy/Bratislava medical journal. 117(11). 677–680. 5 indexed citations
12.
Türedi, Süleyman, Hepsen Mine Serin, Ahmet Menteşe, et al.. (2017). Can ischemia-modified albumin be used to differentiate between generalized seizures and pseudoseizures?. TURKISH JOURNAL OF MEDICAL SCIENCES. 47(1). 282–286. 1 indexed citations
14.
Gündüz, Abdülkadır, Murat Aydın, Süha Türkmen, et al.. (2012). Is grayanotoxin directly responsible for mad honey poisoning-associated seizures. TURKISH JOURNAL OF MEDICAL SCIENCES. 6 indexed citations
15.
Cansu, Ali, et al.. (2011). Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine. Epileptic Disorders. 13(4). 394–400. 6 indexed citations
16.
Cansu, Ayşegül, et al.. (2011). Cardiac echinococcosis associated with cerebrovascular occlusive disease and subcutaneous bullous eruptions and ulcers. Annals of Tropical Paediatrics. 31(3). 251–254. 1 indexed citations
17.
Cansu, Ali, Özgür Ekinci, Ayşe Serdaroğlu, et al.. (2010). Effects of chronic treatment with valproate and oxcarbazepine on testicular development in rats. Seizure. 20(3). 203–207. 17 indexed citations
18.
Turğut, Hasan, et al.. (2010). The Prevalence and Effects of Pectus Excavatum and Pectus Carinatum on the Respiratory Function in Children between 7–14 Years Old. The Indian Journal of Pediatrics. 77(9). 1017–1019. 22 indexed citations
19.
Aktaş, Zeynep, Ali Cansu, Deniz Erdoğan, et al.. (2009). Retinal ganglion cell toxicity due to oxcarbazepine and valproic acid treatment in rat. Seizure. 18(6). 396–399. 23 indexed citations
20.
Cansu, Ali, et al.. (2006). Prevalence of cerebral palsy in Turkish children between the ages of 2 and 16 years. Developmental Medicine & Child Neurology. 48(6). 413–413. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026